论文部分内容阅读
目的:分析探讨采用雾化吸入结合静脉滴注沐舒坦对新生儿肺炎治疗的临床疗效。方法:选择本院收治确诊的84例新生儿肺炎住院患儿,随机分为对照组与实验组,各42例,对照组给予静脉滴注沐舒坦治疗,实验组在对照组基础上结合雾化吸入沐舒坦治疗,比较两组患者的临床治疗效果。结果:实验组治疗总有效率97.6%,显著高于对照组71.4%(P<0.05);肺炎症状消失时间、住院时间均显著缩短,与对照组差异显著(P<0.05);且无明显不良反应(P>0.05)。结论:采用雾化吸入结合静脉滴注沐舒坦对新生儿肺炎治疗的临床疗效显著,可显著提高治疗效果,缩短炎症消失时间和住院的时间,安全可靠,具有临床推广应用的价值。
Objective: To investigate the clinical effect of inhalation combined with intravenous mucosolvan on neonatal pneumonia. Methods: Eighty-four neonates with pneumonia admitted to our hospital were selected and randomly divided into control group and experimental group, 42 cases in each group. The control group was treated with intravenous infusion of mucosolvan. The experimental group was treated with atomization Inhaled mucosolvan treatment, compared the clinical efficacy of two groups of patients. Results: The total effective rate of the experimental group was 97.6%, significantly higher than that of the control group (71.4%, P <0.05). The disappearance time and length of hospital stay of the experimental group were significantly shorter than those of the control group (P <0.05) Reaction (P> 0.05). Conclusion: The therapeutic effect of inhalation combined with intravenous mucosolvan on neonatal pneumonia is significant, which can significantly improve the therapeutic effect, shorten the time of disappearance of inflammation and the time of hospitalization, which is safe and reliable and has the value of clinical popularization and application.